The origin and spread of the HFE-C282Y haemochromatosis mutation

Human Genetics

Volumn 115, Issue 4, 2004, Pages 269-279

  Distante, S ^a   Robson, K J H ^b   Graham Campbell, J ^c   Arnaiz Villena, A ^d   Brissot, P ^e   Worwood, Mark ^f  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e RENNES UNIVERSITY HOSPITAL   (France)

^f CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A3 ANTIGEN; HLA B7 ANTIGEN;

ALLELE; CALCULATION; CULTURAL FACTOR; EUROPE; GENE FREQUENCY; GENE MUTATION; HAPLOTYPE; HEMOCHROMATOSIS; HUMAN; POPULATION GENETICS; POPULATION MIGRATION; POPULATION MOVEMENT PATTERN; PRIORITY JOURNAL; REVIEW; VALIDATION PROCESS;

EUROPE; EVOLUTION, MOLECULAR; GENETICS, POPULATION; GEOGRAPHY; HAPLOTYPES; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; MEMBRANE PROTEINS; MUTATION; POPULATION DYNAMICS;

EID: 4544255777     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-004-1152-4     Document Type: Review

References (86)

1. Adams PC (1994) Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Am J Hematol 45:146-149
2. Ajioka RS, Jorde LB, Gruen JR, Yu P, Dimitrova D, Barrow J, Radisky E, Edwards CQ, Griffen LM, Kushner JP (1997) Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet 60:1439-1447
3. Arnaiz-Viellena A, Rodrigues de Cordoba S, Vela F, Pascual JC, Cervero J, Bootello A (1981) HLA antigens in a sample of the Spanish population: common features among Spaniards, Basques and Sardinians. Hum Genet 58:344-348
4. Arnaiz-Villena A (2001) Historic genomics: an emergent discipline. Hum Immunol 62:869-870
5. Arnaiz-Villena A, Martinezlaso J, Gomezcasado E, Diazeampos N, Santos P, Martinho A, Bredacoimbra H (1997) Relatedness among Basques, Portuguese, Spaniards, and Algerians studied by HLA allelic frequencies and haplotypes. Immunogenetics 47:37-43
6. Arnaiz-Villena A, Gomez-Casdo E, Martinez-Laso J (2002) Population genetic relationships between Mediterranean populations determined by HLA allele distribution and a historic perspective. Tissue Antigens 60:111-121
7. Asberg A, Hveem K, Thorstensen K, Ellekjaer E, Kannelonning K, Fjosne U, Halvorsen TB, Smethurst HBG, Sagen E, Bjerve KS (2001) Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastro 36:1108-1115
8. Batey C, Clarke H, Page RI, Price NS (1994) Cultural atlas of the Viking world. Andromeda, Oxford
9. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, Pockros P, Kosty M, Venditti CP, Phatak PD, Seese NK, Chorney KA, Tenelshof AE, Gerhard GS, Chorney M (1996) Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 22:187-194
10. Beutler E, Felitti V, Gelbart T, Ho N (2000) The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Int Med 133:329-337
11. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G>A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211-218
12. Beutler E, Felitti V, Gelbart T, Waalen J (2003) Haematological effects of the C282Y HFE mutation in homozygous and heterozygous states among subjects of northern and southern European ancestry. Br J Haematol 120:887-893
13. Blanco I, Fernandez E, Bustillo EF (2001) Alpha-1-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys. Clin Genet 60:31-41
14. Bothwell TH, Macphail AP (1998) Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Semin Hematol 35:55-71
15. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP (1996) Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335:1799-1805
16. Burt MJ, George PM, Upton JD, Collett JA, Frampton CMA, Chapman TM, Walmsley TA, Chapman BA (1998) The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43:830-836
17. Byrnes V, Ryan E, Barrett S, Kenny P, Mayne P, Crowe J (2001) Genetic hemochromatosis, a Celtic disease: is it now time for population screening? Genet Test 5:127-130
18. Campbell S, George DK, Robb SD, Spooner R, McDonagh TA, Dargie HJ, Mills PR (2003) The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease. Heart 89:1023-1026
19. Camaschella C, Roetto A, De Gobbi M (2002) Genetic haemochromatosis: genes and mutations associated with iron loading. Best Pract Res Clin Haematol 15:261-276
20. Cardoso CS, Alves H, Mascarenhas M, Goncalves R, Oliveira P, Rodrigues P, Cruz E, de Sousa M, Porto G (2002) Co-selection of the H63D mutation and the HLA-A29 allele: a new paradigm of linkage disequilibrium? Immunogenetics 53:1002-1008
21. Cavalli-Sforza L, Mennozzi P, Piazza A (1994) The history and geography of human genes. Princeton University Press, Princeton
22. Clayton, Lonjou C (1996) Allele and haplotype frequencies for HLA loci in various ethnic groups. In: Charron D (ed) Genetic diversity of HLA, functional and medical implications. EDK, Paris, pp 650-820
23. Crawford DHG, Powell LW, Leggett BA, Francis JS, Fletcher LM, Webb SI, Halliday JW, Jazwinska EC (1995) Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet 57:362-367
24. Cunliffe B (2003) The ancient Celts. Oxford University Press, Oxford
25. Darke C, Guttridge MG, Thompson J, McNamara S, Street J, Thomas M (1998) HLA class I (A, B) and II (DR, DQ) gene and haplotype frequencies in blood donors from Wales. Immunogenetics 15:69-83
26. Darke C, Gurtridge MG, Mcnamara S (1999) Distribution of HFE alleles and HLA-HFE haplotypes in blood donors resident in Wales. Eur J Immunogenet 25 (Suppl 3):263
27. Datz C, Haas T, Rinner H, Sandhofer F, Patsch W, Paulweber B (1998) Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency? Clin Chem 44:2429-2432
28. De Braekeleer M (1993) A prevalence and fertility study of haemochromatosis in Saguenay-Lac-Saint-Jean. Ann Hum Biol 20:501-505
29. 1-antitrypsin deficiency. Chest 122:1818-1829
30. Eisensmith RC, Okano Y, Dasovich M, Wang T, Guttler F, Lou H, Guldberg P, Lichterkonecki U, Konecki DS, Svensson E, Hagenfeldt L, Rey F, Munnich A, Lyonnet S, Cockburn F, Connor JM, Pembrey ME, Smith I, Gitzelmann R, Steinmann B, Apold J, Eiken HG, Giovannini M, Riva E, Longhi R, Romano C, Cerone R, Naughten ER, Mullins C, Cahalane S, Ozalp I, Fekete G, Schuler D, Berencsi GY, Nasz I, Brdicka R, Kamaryt J, Pijackova A, Cabalska B, Boszkowa K, Schwartz E, Kalinin VN, Jin L, Chakraborty R, Woo SLC (1992) Multiple origins for phenylketonuria in Europe. Am J Hum Genet 51:1355-1365
31. Eisensmith RC, Goltsov AA, Oneill C, Tyfield LA, Schwartz EI, Kuzmin AI, Baranovskaya SS, Tsukerman GL, Treacy E, Scriver CR, Guttler F, Guldberg P, Eiken HG, Apold J, Svensson E, Naughten E, Cahalane SF, Croke DT, Cockburn F, Woo SLC (1995) Recurrence of the R408W mutation in the phenylalanine-hydroxylase locus in Europeans. Am J Hum Genet 56:278-286
32. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, Mcclelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408
33. Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC (1997) The hemochromatosis founder mutation in HLA-H disrupts beta(2)-microglobulin interaction and cell surface expression. J Biol Chem 272:14025-14028
34. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 95:1472-1477
35. Finch T, Lawlor E, Borton M, Barnes CA, McNamara S, Oriordan J, McCann SR, Darke C (1997) Distribution of HLA-A, B and DR genes and haplotypes in the Irish population. Exp Clin Immunogenet 14:250-263
36. Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783-788
37. Gkiasta M, Russell T, Shennan S, Steele J (2003) Neolithic transition in Europe: the radiocarbon record revisited. Antiquity 77:45-62
38. Helgason A, Hickey E, Goodacre S, Bosnes V, Stefansson K, Ward R, Sykes B (2001) mtDNA and the islands of the north Atlantic: estimating the proportions of Norse and Gaelic ancestry. Am J Hum Genet 68:723-737
39. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M (2001) HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 114:474-484
40. Kaplan NL, Lewis PO, Weir BS (1994) Age of the delta-F508 cystic-fibrosis mutation. Nat Genet 8:216
41. Krawczak M, Zschocke J (2003) A role for overdominant selection in phenylketonuria? Evidence from molecular data. Hum Mutat 21:394-397
42. Lebron JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, Feder JN, Bjorkman PJ (1998) Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93:111-123
43. Lucotte G (2001) Frequency analysis and allele map in favor of the Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol Dis 27:549-556
44. Lucotte G, Dieterlen F (2003) A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells Mol Dis 31:262-267
45. 1-antitrypsin deficiency. Thorax 59:164-169
46. Malfroy L, Roth MP, Carrington M, Borot N, Volz A, Ziegler A, Coppin H (1997) Heterogeneity in rates of recombination in the 6-Mb region telomeric to the human major histocompatibility complex. Genomics 43:226-231
47. McCune CA, Al-Jader LN, May A, Hayes SL, Jackson HA, Worwood M (2002) Hereditary haemochromatosis: only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload. Hum Genet 111:538-543
48. McEvedy C (2002) The new Penguin atlas of ancient history. Penguin Books, London
49. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJH (2000) Georgraphy of HFE C282Y and H63D mutations. Genet Test 4:183-198
50. Milman N, Pedersen P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 64:36-47
51. Milman N, Sorensen SA (1983) Idiopathic haemochromatosis. Was the ancestor a Danish Viking? Ugeskr Laeger 145:832-833
52. Moalem S, Percy ME, Kruck TPA, Gelbart RR (2002) Epidemic pathogenic selection: an explanation for hereditary hemochromatosis? Med Hypotheses 59:325-329
53. Moirand R, Guyader D, Mendler MH, Jouanolle AM, Le Gall JY, David V, Brissot P, Deugnier Y (2002) HFE based re-evaluation of heterozygous hemochromatosis. Am J Med Genet 111:356-361
54. Morral N, Bertranpetit J, Estivill X, Nunes V, Casals T, Gimenez J, Reis A, Varonmateeva R, Macek M, Kalaydjieva L, Angelicheva D, Dancheva R, Romeo G, Russo MP, Garnerone S, Restagno G, Ferrari M, Magnani C, Claustres M, Desgeorges M, Schwartz M, Schwarz M, Dallapiccola B, Novelli G, Ferec C, Dearce M, Nemeti M, Kere T, Anvret M, Dahl N, Kadasi L (1994) The origin of the major cystic-fibrosis mutation (delta-F508) in European populations. Nat Genet 7:169-175
55. Motulsky AG (1979) Genetics of hemochromatosis. N Engl J Med 301:1291
56. Muller CR, Ehninger G, Goldmann SF (2003) Gene and haplotype frequencies for the loci HLA-A, HLA-B, and HLA-DR based on over 13,000 German blood donors. Hum Immunol 64:137-151
57. Mura C, Raguenes O, Ferec C (1999) HFE mutations in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 93:2202-2205
58. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (Usf2) knockout mice. Proc Natl Acad Sci USA 98:8780-8785
59. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G (1996) Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110:1107-1119
60. Olsson KS, Ritter B (1981) Idiopatisk hemokromatose. Tidsskrift for Den Norske Laegeforen 29:101
61. Papanikolaou G, Politou M, Terpos E, Fourlemadis S, Sakellaropoulos N, Loukopoulos D (2000) Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity. Blood Cells Mol Dis 26:163-168
62. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, l'Oréal O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811-7819
63. Piperno A, Arosio C, Fargion S, Roetto A, Nicoli C, Girelli D, Sbaiz L, Gasparini P, Boari G, Sampietro M, Camaschella C (1996) The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients. Hepatology 24:43-46
64. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, Vergani A, Fraquelli M, Girelli D, Pasquero P, Roetto A, Gasparini P, Fargion S, Conte D, Camaschella C (1998) Heterogeneity of hemochromatosis in Italy. Gastroenterology 114:996-1002
65. Powell LW, Summers KM, Board PG, Axelsen E, Webb S, Halliday JW (1990) Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology 98:1625-1632
66. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F (1999) The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immuopathological diseases. Immunol Rev 167:257-274
67. Raha-Chowdhury, Gruen JR (2000) Localization, allelic heterogeneity, and origins of the hemochromatosis gene. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology, diagnosis and treament. Cambridge University Press, Cambridge, pp 75-90
68. Raha-Chowdhury R, Bowen DJ, Stone C, Pointon JJ, Terwilliger JD, Shearman JD, Robson KJH, Bomford A, Worwood M (1995) New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum Mol Genet 4:1869-1874
69. Richards HD (2000) Viking age England. Tempus, Stroud
70. Risch N (1997) Haemochromatosis, HFE and genetic complexity. Nat Genet 17:375-376
71. Rochette J, Pointon JJ, Fisher CA, Perera G, Arambepola M, Arichchi DSK, De Silva S, Vandwalle JL, Monti JP, Old JM, Merryweather-Clarke AT, Weatherall DJ, Robson KJH (1999) Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet 64:1056-1062
72. Rossi E, Olynyk JK, Cullen DJ, Papadopoulos G, Bulsara M, Summerville L, Powell LW (2000) Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women. Clin Chem 46:162-166
73. Sabeti PC, Reich DE, Higgins JM, Levine HZP, Richter DJ, Schaffner SF, Gabriel SB, Platko JV, Patterson NJ, McDonald GJ, Ackerman HC, Campbell SJ, Altshuler DCR, Kwiatkowski D, Ward R, Lander ES (2002) Detecting recent positive selection in the human genome from haplotype structure. Nature 419:832-837
74. Schipper RF, Damaro J, Bakker JT, Vanrood JJ, Oudshoorn M (1997) HLA gene and haplotype frequencies in bone marrow donors worldwide registries. Hum Immunol 52:54-71
75. Simon M, Pawlotsky Y, Bourel M, Fauchet R, Genetet B (1975) Hémochromatose idopathique. Maladie associée à l'antigène tissulaire HL-A3? Nouvelle Presse Med 4:1432
76. Simon M, Alexandre A, Fauchet R, Genetet B, Bourel M (1980) The genetics of hemochromatosis. In: Steinberg AG, Bearn AG, Motulsky AG, Childs B (eds) Progress in medical genetics. Saunders, Philadelphia, pp 135-168
77. Smith JM, Haigh J (1974) The hitch-hiking effect of a favourable gene. Genet Res 23:23-25
78. Thomas J (2003) Thoughts on the 'repacked' Neolithic revolution. Antiquity 77:67-74
79. Thomas W, Fullan A, Loeb DB, Mcclelland EE, Bacon BR, Wolff RK (1998) A haplotype and linkage disequilibrium analysis of the hereditary hemochromatosis gene region. Hum Genet 102:517-525
80. Weale ME, Weiss DA, Jager RE, Bradman N, Thomas MG (2002) Y chromosome evidence for Anglo-Saxon mass migration. Mol Biol and Evol 19:1008-1021
81. Willis G, Scott DGI, Jennings BA, Smith K, Bukhari M, Wimperis JZ (2002) HFE mutations in an inflammatory arthritis population. Rheumatology 41:176-179
82. Wilson JF, Weiss DA, Richards M, Thomas MG, Bradman N, Goldstein DB (2001) Genetic evidence for different male and female roles during cultural transitions in the British Isles. Proc Natl Acad Sci USA 98:5078-5083
83. Yaouanq J (2000) Human leukocyte antigen (HLA) assocoiation and typing in hemochromatosis. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology, diagnosis and treatment. Cambridge University Press, Cambridge, pp 63-74
84. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang JX, Fei Y, Brunt EM, Ruddy DA, Prass CE, Schatzman RC, Oneill R, Britton RS, Bacon BR, Sly WS (1998) HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 95:2492-2497
85. Zschocke J (2003) Phenylketonuria mutations in Europe. Hum Mutat 21:345-356
86. Zschocke J, Mallory JP, Eiken HG, Nevin NC (1997) Phenylketonuria and the peoples of Northern Ireland. Hum Genet 100:189-194